The Use of Renal Guard System in Patients Undergoing CRT Implantation

N/AWithdrawnNCT01936142

Tel-Aviv Sourasky Medical Center

Overview

The purpose of this study is to determine whether the use of RenalGuard system which creates high urine output with fluid balancing may prevent contrast induced nephropathy in patient undergoing cardiac resynchronization therapy (CRT) implantation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Conditions

Acute Kidney Injury

Interventions

Use of RenalGuardDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. eligible for CRT implantation 2. estimated GFR \< 60ml/min/1.73m2 Exclusion Criteria: 1. On Dialysis 2. Sensitivity to Furosemide 3. Contraindication for urinary catheter 4. Pregnancy

Locations (1)

Tel Aviv Souraky MC

Tel Aviv, Israel

Outcomes

Primary Outcomes

Change in Renal function

Change in Renal function will be measured by change in serum creatinine (mg/dl)

Time frame: 24 and 48 hours post implantation and 8-11 days post implantation, 6 month post implantaion

Secondary Outcomes

Left ventricular lead implantation success

Time frame: 1 day post implantation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.